506 related articles for article (PubMed ID: 3874297)
1. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
Kikuchi K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
[TBL] [Abstract][Full Text] [Related]
6. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
Han T; Ozer H; Minowada J
Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
[TBL] [Abstract][Full Text] [Related]
8. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
[TBL] [Abstract][Full Text] [Related]
9. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
[TBL] [Abstract][Full Text] [Related]
10. [Analysis and classification of leukemia and malignant lymphoma cells using monoclonal antibodies].
Uede T; Kikuchi K
Nihon Rinsho; 1983; 41(4):815-20. PubMed ID: 6350650
[No Abstract] [Full Text] [Related]
11. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
12. Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies.
Tobinai K; Nagai M; Setoya T; Shibata T; Minato K; Shimoyama M
Jpn J Clin Oncol; 1983; 13 Suppl 2():237-44. PubMed ID: 6603532
[TBL] [Abstract][Full Text] [Related]
13. [Immunologic phenotyping of cutaneous lymphomas].
Kaudewitz P; Burg G; Smolle J; Braun-Falco O
Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
[TBL] [Abstract][Full Text] [Related]
14. The immunological classification of leukaemia based on a rapid microcytotoxicity test.
Billing RJ; Foon KA; Linker-Israeli M
Clin Exp Immunol; 1982 Jul; 49(1):142-8. PubMed ID: 6957278
[TBL] [Abstract][Full Text] [Related]
15. Surface marker expression of human B-cell lymphomas.
Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
[TBL] [Abstract][Full Text] [Related]
16. [Surface marker analysis of leukemic cells by using antimyeloid monoclonal antibodies].
Ohto H; Maeda H; Tohyama H
Rinsho Ketsueki; 1985 Aug; 26(8):1249-57. PubMed ID: 3877826
[No Abstract] [Full Text] [Related]
17. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
[TBL] [Abstract][Full Text] [Related]
18. Immunologic characterization of T-lymphoproliferative disorders by monoclonal antibodies.
Koubek K; Hrodek O; Starý J; Chudomel V; Malasková V
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):649-57. PubMed ID: 2416641
[TBL] [Abstract][Full Text] [Related]
19. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodies.
Mann DL; Haynes BF; Thomas C; Cole D; Fauci AS; Poplack DG
J Natl Cancer Inst; 1983 Jul; 71(1):11-7. PubMed ID: 6602900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
